Dr. M. Ali Khan of the Doheny Eye Institute at the University of California Los Angeles and Dr. Ajay Kuriyan of the University of Rochester join Jay to preview the January special issue of Retinal Physician (link: http://www.retinalphysician.com) concerning OCT angiography. 

Dr. M. Ali Khan of the Doheny Eye Institute at the University of California Los Angeles and Dr. Ajay Kuriyan of the University of Rochester join for a journal club discussion of two recent articles in JAMA Ophthalmology:

Protocol U Six-Month Results (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2663061)

Association Between Ophthalmologist Age and Unsolicited Patient Complaints (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2664085)

########

[1:16] Introduction

[1:50] Background and Results of the first paper, entitled “Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients with Persistent Diabetic Macular Edema.”

[3:24] Take-home points of the article.

[4:00] Did the results surprise you?

[5:25] What do you think about the long-term effectiveness of steroid treatment?

[9:45] Discussion of IOP results between dexamethasone and triamcinolone.

[13:15] Summary of the second paper, entitled “Association Between Ophthalmologist Age and Unsolicited Patient Complaints.”

[14:40] What were your take-away’s from this paper?

[17:18] The only subspecialty with a significant result was neuro-ophthalmology – what are your thoughts as to why this may be?

[21:40] Discussion of the best ways to receive and use feedback, and how to best make a recommendation to a patient.

[28:15] Discussion of time spent with the physician and how to improve efficiency to maximize this time.

[29:45] Football talk!

[32:10] Conclusion

########

Dr. Mina Chung of University of Rochester joins the show to talk approaching vitrectomy in eyes with a keratoprosthesis and adaptive optics.

########

[0:52] Introduction

[1:08] Why did you first decide to do ophthalmology, and then retina?

[2:52] Discussion of ability versus desire/drive, when it comes to choosing a sub-speciality.

[4:40] Discussion of vitrectomy in cases of keratoprosthesis.

[8:00] Pearls regarding how to actually perform the vitrectomy.

[12:37] How do you manage to see wide enough in periphery? Do you shave these cases or not?

[17:30] Can you give a quick summary of adaptive optics and its implications for the future?

[21:57] What were some of the things that influenced you to switch jobs, and what were the pros/cons of this move?

[24:55] What have been your personal experiences regarding progress of women in the medical field and the field of retina?

[27:05] Conclusion

########

Dr. Amy Schefler of Retina Consultants of Houston talks retinoblastoma diagnosis and management and what is on the horizon. Other topics covered include advice on interviewing residency applicants and remaining challenges for women in medicine.

##########

[0:55] Introduction

[1:15] How did you first decide on ophthalmology, and how did you end up in retina and ocular oncology?

[3:30] For those interested in an oncology fellowship, what are your thoughts of doing a retina fellowship first versus afterward?

[5:30] For you, what are the pros and cons of academics and private practice?

[9:18] What are the useful pearls for recognizing retinoblastoma and distinguishing it from “mimickers?”

[13:42] After you make the diagnosis, how is treatment changing and what treatment do you recommend?

[17:25] What are your thoughts of taking an aqueous sample to obtain genetic information on a tumor?

[21:15] In your experience working with applicants, what can you do to be a good interviewer?

[23:42] What are your thoughts on the challenges still present for women in retina, and what do you see going forward?

[29:00] Conclusion

##########

Dr. Jerry Sebag of the VMR (Vitreous, Macula, Retina) Institute in Huntington Beach, CA joins the program to discuss his background, research, and clinical experience on treatments including vitrectomy for vision degrading vitreopathy, or visually significant vitreous floaters. As per Dr. Sebag’s request you will find a list of relevant articles about this condition for reference below.

Relevant Bibliography

###########################

[1:25] Introduction

[1:45] What drew you to ophthalmology, and then to retina?

[3:15] You are well-known for speaking about pars plana vitrectomy for visually-significant vitreous opacities or floaters. How did you first get involved in this field?

[6:15] How do you select patients for this procedure in your practice?

[11:10] How technically do you prefer to perform the surgeries?

[13:35] How do you minimize iatrogenic breaks?

[15:20] Why have retinal specialists been resistant against this surgery? How do you counter this?

[17:30] How does history of detachment in fellow eye affect your decision-making?

[18:58] What do you expect going forward?

[22:40] What would you say to someone trying to “swim upstream” with a new idea?

[25:43] Conclusion

###########################